JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report) shares were up 32.3% during mid-day trading on Friday . The stock traded as high as $5.00 and last traded at $5.00. Approximately 680 shares changed hands during trading, an increase of 132% from the average daily volume of 293 shares. The stock had previously closed at $3.78.
JCR Pharmaceuticals Trading Up 32.3%
The company has a 50 day moving average of $4.21 and a 200-day moving average of $4.45.
About JCR Pharmaceuticals
JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.
Recommended Stories
- Five stocks we like better than JCR Pharmaceuticals
- Buy P&G Now, Before It Sets A New All-Time High
- Why Pure Storage Is a Core Investment for the AI Era
- How to Use the MarketBeat Excel Dividend Calculator
- 2025: A Pivotal Year for Smart Glasses As Meta Invests in Ray-Ban
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Unity’s New Ad Solutions Drive Stock to 52-Week High
Receive News & Ratings for JCR Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JCR Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
